Cross-fund · 4 holders
SPRY
ARS PHARMACEUTICALS INC
CUSIP 82835W108
4
Tracked holders
$143.9M
Aggregate value
16,344,235
Shares
4
Active funds
Funds holding SPRY
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Millennium | Multi-Strategy | Q1 2026 | $48.0M | 0.02% | +2,814,513 | +88.8% |
| Vanguard | Institutional | Q4 2025 | $40.9M | — | +8,871 | +0.3% |
| BlackRock | Institutional | Q1 2026 | $40.2M | — | -73,063 | -1.4% |
| Citadel | Multi-Strategy | Q1 2026 | $14.8M | — | -200,984 | -9.8% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.